Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Saunders K, Cipriani A, Rendell J, Attenburrow M, Nelissen N, Bilderbeck A, Vasudevan S, Churchill G, Goodwin G, Nobre A, Harmer C, Harrison P, Geddes J. Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial. Trials 2016, 17: 116. PMID: 26936776, PMCID: PMC4776410, DOI: 10.1186/s13063-016-1230-7.Peer-Reviewed Original ResearchMeSH KeywordsAdultAffectAntimanic AgentsBiomarkersBipolar DisorderBrainClinical ProtocolsCognitionDouble-Blind MethodEnglandFemaleGene Expression RegulationHumansLithium CarbonateMagnetic Resonance ImagingMagnetoencephalographyMaleNeuropsychological TestsProspective StudiesPsychiatric Status Rating ScalesResearch DesignTime FactorsTreatment OutcomeYoung AdultConceptsBipolar disorderLithium trialExperimental medicine modelEffects of lithium carbonateMulti-modal investigationsMood stabilisersMood instabilityPlacebo-controlled studyCognitive testsLithium treatmentLithium carbonateDouble-blindDisordersMoodCircadian effectsMedicine modelBiochemical effectsRandomised controlled trialsTherapeutic responseParticipantsEarly effectsSide effectsClinical useFMRIEffective drugsInnovative approaches to bipolar disorder and its treatment
Harrison P, Cipriani A, Harmer C, Nobre A, Saunders K, Goodwin G, Geddes J. Innovative approaches to bipolar disorder and its treatment. Annals Of The New York Academy Of Sciences 2016, 1366: 76-89. PMID: 27111134, PMCID: PMC4850752, DOI: 10.1111/nyas.13048.Peer-Reviewed Original ResearchConceptsBipolar disorderRelevant to bipolar disorderIndicators of target engagementMood stabilizersMood instabilityPsychiatric disordersDisorder pathophysiologyCalcium channel geneDrug effectsDisordersPharmacological interventionsTarget engagementTherapeutic responseClinical profileClinical episodesClinical phenotypeChannel genesNew treatmentsStem cellsKey pathwaysIncreasing evidenceMoodTreatmentPhenotypeExperimental medicine